The Food and Drug Administration recently approved a third drug indicated for treatment of fibromyalgia. Milnacipran, made by Forest Laboratories and Cypres Bioscience, is a selective serotonin and norepinephrine dual reuptake inhibitor. It will be available to consumers in March. The two other medicines approved by the FDA... Read more
Congratulations to everyone who shared their incredible artwork and creativity this year. In no particular order, you can see the finalists below. Be sure to check out the slideshow of the finalists' artwork!
Joani BurtardPoetry: Dialogue with Pain
SqueegiImage: Sidewalk of Healing Powers
Suzanne K. LeowPoetry: Out of the... Read more
In 45 BC Marcus Tullius Cicero wrote a text he entitled "De Finibus Bonorum et Malorum" (The Extremes of Good and Evil). A line from that text has been used since the 1500s by print and typesetters as the standard sample print text which is popularly known as the "Lorem ipsum." When you see a mock layout for a printed text, often it will include... Read more
Great News! On July 31st, Senators Hatch (Utah) and Dodd (Connecticut) introduced in the Senate the National Pain Care Policy Act. This is the first time the bill has been introduced in the Senate and, except for some minor changes, the language is the same as the bill that is in the House of Representatives. We all need to come together now... Read more
Increasingly, people are turning to the internet to shop for many of the luxuries and necessities. This is also true about the use of Internet Pharmacies. Clearly, there are the usual advantages of internet shopping--convenience, sometimes price, sometimes variety. But purchasing medicines online presents some significant risks that we should... Read more